SU475772A3 - Способ получени 2-алкиламинодигидропиридинов - Google Patents

Способ получени 2-алкиламинодигидропиридинов

Info

Publication number
SU475772A3
SU475772A3 SU1955736A SU1955736A SU475772A3 SU 475772 A3 SU475772 A3 SU 475772A3 SU 1955736 A SU1955736 A SU 1955736A SU 1955736 A SU1955736 A SU 1955736A SU 475772 A3 SU475772 A3 SU 475772A3
Authority
SU
USSR - Soviet Union
Prior art keywords
ester
methyl
acetoacetic
ethyl
acid
Prior art date
Application number
SU1955736A
Other languages
English (en)
Russian (ru)
Inventor
Майер Хорст
Боссерт Фридрих
Фатер Вульф
Штепель Курт
Original Assignee
Байер Аг (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Аг (Фирма) filed Critical Байер Аг (Фирма)
Application granted granted Critical
Publication of SU475772A3 publication Critical patent/SU475772A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SU1955736A 1972-08-12 1973-08-08 Способ получени 2-алкиламинодигидропиридинов SU475772A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2239815A DE2239815C2 (de) 1972-08-12 1972-08-12 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
SU475772A3 true SU475772A3 (ru) 1975-06-30

Family

ID=5853453

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1955736A SU475772A3 (ru) 1972-08-12 1973-08-08 Способ получени 2-алкиламинодигидропиридинов

Country Status (29)

Country Link
US (1) US3959292A (enExample)
JP (1) JPS5626660B2 (enExample)
KR (1) KR780000072B1 (enExample)
AT (1) AT327194B (enExample)
AU (1) AU469267B2 (enExample)
BE (1) BE803474A (enExample)
BG (1) BG22816A3 (enExample)
CA (1) CA1016945A (enExample)
CH (1) CH583196A5 (enExample)
CS (1) CS178892B2 (enExample)
DD (1) DD109627A5 (enExample)
DE (1) DE2239815C2 (enExample)
DK (1) DK136062C (enExample)
ES (1) ES417807A1 (enExample)
FI (1) FI55998C (enExample)
FR (1) FR2195450B1 (enExample)
GB (1) GB1384219A (enExample)
HU (1) HU167991B (enExample)
IE (1) IE37989B1 (enExample)
IL (1) IL42933A (enExample)
LU (1) LU68206A1 (enExample)
NL (1) NL7311031A (enExample)
NO (1) NO139130C (enExample)
PL (1) PL89396B1 (enExample)
RO (1) RO62914A (enExample)
SE (1) SE386164B (enExample)
SU (1) SU475772A3 (enExample)
YU (1) YU36172B (enExample)
ZA (1) ZA735460B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639257A1 (de) * 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4442100A (en) * 1979-12-11 1984-04-10 Bayer Aktiengesellschaft Substituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal use
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
CA1267416A (en) 1985-06-17 1990-04-03 Ila Sircar 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
SE8701172D0 (sv) * 1987-03-20 1987-03-20 Sandvik Ab Whiskerforsterkt keramiskt skerverktyg
JPWO2019124203A1 (ja) 2017-12-22 2020-10-22 東レ株式会社 テープ状プリプレグ及びその製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester

Also Published As

Publication number Publication date
DK136062C (da) 1978-01-09
FR2195450B1 (enExample) 1977-09-09
ATA707073A (de) 1975-04-15
FI55998C (fi) 1979-11-12
RO62914A (fr) 1977-11-15
KR780000072B1 (en) 1978-03-30
LU68206A1 (enExample) 1973-10-16
FR2195450A1 (enExample) 1974-03-08
YU213373A (en) 1981-06-30
IE37989B1 (en) 1977-11-23
ES417807A1 (es) 1976-03-01
DK136062B (da) 1977-08-08
YU36172B (en) 1982-02-25
DE2239815C2 (de) 1983-02-10
DD109627A5 (enExample) 1974-11-12
CH583196A5 (enExample) 1976-12-31
GB1384219A (en) 1975-02-19
DE2239815A1 (de) 1974-02-21
IE37989L (en) 1974-02-12
US3959292A (en) 1976-05-25
IL42933A (en) 1977-04-29
CS178892B2 (en) 1977-10-31
ZA735460B (en) 1974-07-31
NO139130C (no) 1979-01-10
FI55998B (fi) 1979-07-31
CA1016945A (en) 1977-09-06
BG22816A3 (bg) 1977-04-20
AU469267B2 (en) 1976-02-05
IL42933A0 (en) 1973-11-28
BE803474A (fr) 1974-02-11
JPS5626660B2 (enExample) 1981-06-19
AU5912473A (en) 1975-02-13
PL89396B1 (enExample) 1976-11-30
HU167991B (enExample) 1976-02-28
NO139130B (no) 1978-10-02
JPS4945079A (enExample) 1974-04-27
NL7311031A (enExample) 1974-02-14
SE386164B (sv) 1976-08-02
AT327194B (de) 1976-01-26

Similar Documents

Publication Publication Date Title
SU515452A3 (ru) Способ получени сложных эфиров 1,4-дигидропиридинкарбоновой кислоты или их солей
SU475771A3 (ru) Способ получени несимметричных 1,4-дигидропиридинов
SU509221A3 (ru) Способ получени 1,4-дигидро-пиридинов или их солей
SU464111A3 (ru) Способ получени несимметричных эфиров 1,4-дигидропиридинкарбоновой кислоты
US3773773A (en) N-alkyl-1,4-dihydropyridines and their production
CS259894B2 (en) Method of substituted nicotinates preparation
CN102702082A (zh) 2-取代的-5-((1-烷硫基)烷基)吡啶的制备方法
SU421193A3 (ru) Способ получения несимметричных эфиров 1,4-дигидропиридиндикарбоновых кислот
US4198339A (en) 1,3-Dithietane-2-carboxylic acids and the preparation thereof
KR930019628A (ko) 피리딘디카르복실레이트 화합물의 제조방법
CA1176255A (en) 1,4-dihydropyridine derivatives and processes for preparing the same
US4703119A (en) Intermediates of optically active 1,4-dihydropyridines
KR930008232B1 (ko) 플루오로메틸-치환 피리딘 카보디티오에이트의 제조방법
SU1384588A1 (ru) Способ получени ацеталей или кеталей фуранового р да
SU455545A3 (ru) Способ получени пироно-рифамицинов
SU628819A3 (ru) Способ получени производных тетрагидротиено /3,2-с/пиридина
CA2095206A1 (en) 4- or 5-(sulf)imido- and -(sulfon)amidopyridines and their pyridine n-oxides, processes for their preparation, and their use as medicaments
US4289894A (en) Pentachlorophenyl-phenyl malonate compound suitable for use as acylating agents
SU435612A1 (ru) Способ получения несимметричных эфир08 1,4-дигидропиридиндикарбоновых кислот
KR930008233B1 (ko) 플루오로메틸이 치환된 피리딘 디카르복실레이트의 제조방법
HAYASHI et al. Studies on Antitumor Substances. XI. Reactions of Bunte Salts with Nucleophiles
Mitkin et al. Indoles from 3-nitropyridinium salts: an extension of the transformation method on 5-substituted indoles
JPH0314307B2 (enExample)
SU496282A1 (ru) Способ получени поли-1-окси-2,2,2трихлорэтилфосфонатов
SU458557A1 (ru) Способ получени 2-(ацетилметил)бензо-1,3-оксатиолов